Bionoid Pharma Pink Sheet Forward View - Price Action Indicator
| BINP Stock | USD 0.03 0.00 0.00% |
Bionoid Pink Sheet outlook is based on your current time horizon.
As of today, the relative strength index (RSI) of Bionoid Pharma's share price is approaching 49 suggesting that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bionoid Pharma, making its price go up or down. Momentum 49
Impartial
Oversold | Overbought |
Using Bionoid Pharma hype-based prediction, you can estimate the value of Bionoid Pharma from the perspective of Bionoid Pharma response to recently generated media hype and the effects of current headlines on its competitors.
Bionoid Pharma after-hype prediction price | USD 0.0284 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bionoid |
Bionoid Pharma Additional Predictive Modules
Most predictive techniques to examine Bionoid price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bionoid using various technical indicators. When you analyze Bionoid charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Bionoid Pharma Volatility | Backtest Bionoid Pharma | Information Ratio |
Bionoid Pharma Trading Date Momentum
| On January 29 2026 Bionoid Pharma was traded for 0.03 at the closing time. The top price for the day was 0.03 and the lowest listed price was 0.03 . There was no trading activity during the period 0.0. Lack of trading volume on January 29, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Bionoid Pharma to competition
Bionoid Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bionoid Pharma pink sheet to make a market-neutral strategy. Peer analysis of Bionoid Pharma could also be used in its relative valuation, which is a method of valuing Bionoid Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bionoid Pharma Market Strength Events
Market strength indicators help investors to evaluate how Bionoid Pharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bionoid Pharma shares will generate the highest return on investment. By undertsting and applying Bionoid Pharma pink sheet market strength indicators, traders can identify Bionoid Pharma entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0284 | |||
| Day Typical Price | 0.0284 | |||
| Relative Strength Index | 49.98 |
Story Coverage note for Bionoid Pharma
The number of cover stories for Bionoid Pharma depends on current market conditions and Bionoid Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bionoid Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bionoid Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Bionoid Pink Sheet Analysis
When running Bionoid Pharma's price analysis, check to measure Bionoid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionoid Pharma is operating at the current time. Most of Bionoid Pharma's value examination focuses on studying past and present price action to predict the probability of Bionoid Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionoid Pharma's price. Additionally, you may evaluate how the addition of Bionoid Pharma to your portfolios can decrease your overall portfolio volatility.